DAP expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62725388719309E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.64568358940187E-12 |
Normal-vs-Stage2 |
1.86906046195645E-12 |
Normal-vs-Stage3 |
5.55111512312578E-16 |
Normal-vs-Stage4 |
6.10622663543836E-15 |
Stage1-vs-Stage2 |
6.366400E-01 |
Stage1-vs-Stage3 |
2.056200E-01 |
Stage1-vs-Stage4 |
3.702200E-01 |
Stage2-vs-Stage3 |
5.506000E-01 |
Stage2-vs-Stage4 |
7.808400E-01 |
Stage3-vs-Stage4 |
7.043600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.88498130835069E-15 |
Normal-vs-AfricanAmerican |
1.63125069008174E-12 |
Normal-vs-Asian |
2.04960000083076E-08 |
Caucasian-vs-AfricanAmerican |
2.836400E-01 |
Caucasian-vs-Asian |
1.489200E-01 |
AfricanAmerican-vs-Asian |
6.164600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
1.6251444634463E-12 |
Male-vs-Female |
2.263000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.69153580031889E-12 |
Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(61-80Yrs) |
1.4432899320127E-15 |
Normal-vs-Age(81-100Yrs) |
1.98079996849287E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.922050E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.342200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.081400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.768800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.773000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.682600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.17783560682483E-12 |
Normal-vs-Grade 2 |
1.62658775337832E-12 |
Normal-vs-Grade 3 |
1.62458935193399E-12 |
Normal-vs-Grade 4 |
1.62536650805123E-12 |
Grade 1-vs-Grade 2 |
8.444000E-01 |
Grade 1-vs-Grade 3 |
5.719200E-01 |
Grade 1-vs-Grade 4 |
5.090000E-01 |
Grade 2-vs-Grade 3 |
5.978200E-01 |
Grade 2-vs-Grade 4 |
2.825400E-01 |
Grade 3-vs-Grade 4 |
1.844210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62470037423645E-12 |
Normal-vs-ccB subtype |
2.51639820092464E-11 |
ccA subtype-vs-ccB subtype |
6.590400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62492241884138E-12 |
Normal-vs-N1 |
4.049100E-04 |
N0-vs-N1 |
5.846800E-01 |
|
|